Gregory Davis
Chairman chez INOTIV, INC.
Fortune : 459 021 $ au 31/03/2024
Profil
Gregory C.
Davis's current job is Chairman at Inotiv, Inc. Dr. Davis's former jobs include Executive Director & COO-Xigris Product Team at Eli Lilly & Co. from 1992 to 2012, and Vice President-Regulatory Affairs & Quality at Calibrium LLC from 2014 to 2015.
Dr. Davis's education history includes a doctorate degree from Purdue University and an undergraduate degree from Southeast Missouri State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INOTIV, INC.
0,16% | 01/01/2024 | 41 958 ( 0,16% ) | 459 021 $ | 31/03/2024 |
Postes actifs de Gregory Davis
| Sociétés | Poste | Début |
|---|---|---|
| INOTIV, INC. | Chairman | 01/08/2017 |
Anciens postes connus de Gregory Davis
| Sociétés | Poste | Fin |
|---|---|---|
Calibrium LLC
 Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN. | General Counsel | 01/01/2015 |
| ELI LILLY AND COMPANY | Director/Board Member | 01/12/2012 |
Formation de Gregory Davis
| Purdue University | Doctorate Degree |
| Southeast Missouri State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| INOTIV, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Calibrium LLC
Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN. | Health Technology |
